home / stock / gntlf / gntlf news

GNTLF News and Press, Genetic Techs Ltd Aud From 09/11/23

Stock Information
Company Name: Genetic Techs Ltd Aud
Stock Symbol: GNTLF
Market: OTC
Website: gtglabs.com
Menu
GNTLF GNTLF Quote GNTLF Short GNTLF News GNTLF Articles GNTLF Message Board
Get GNTLF Alerts

News, Short Squeeze, Breakout and More Instantly...
GNTLF - GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner

MELBOURNE, Australia, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce that a Medical Research Future Fund...
GNTLF - Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV

MELBOURNE, Australia, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health, wellness and serious disease is pleased to advise that RedChip Companie...

GNTLF - Annual Results - Momentum Building on our Commercial Plans

MELBOURNE, Australia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health, wellness and serious disease is pleased to report annual results for the...

GNTLF - Genetic Technologies Limited Announces Updated Investor Presentation

MELBOURNE, Australia, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG, “Company”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to provide an update on the company’s activities via the lates...
GNTLF - Genetic Technologies Limited (GENE) Q4 2023 Earnings Call Transcript

2023-08-09 00:11:04 ET Genetic Technologies Limited (GENE) Q4 2023 Earnings Conference Call August 08, 2023 07:15 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer Tony Di Pietro - Chief Financial Officer C...

GNTLF - Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume

MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, is pleased to provide this Quarterly Business Upda...

GNTLF - Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

MELBOURNE, Australia, July 21, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness and serious disease, advises that it has received notification (the “Notification”) from The Nasda...
GNTLF - Genetic Technologies embraces global vision for genomic-integrated healthcare

(NewsDirect) Genetic Technologies Ltd (ASX:GTG) CEO Simon Morriss is back with Proactive’s Elisha Newell to outline the company’s latest endeavours in the predictive genetics space. Lauded as a pioneer in clinical genetics tech, GTG is working on early-stage tools that help clin...

GNTLF - GeneType featured on U.S. National TV to raise Breast Cancer Awareness

MELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce that the Company’s geneType Brea...

GNTLF - Genetic Technologies Limited (GENE) Q3 2023 Earnings Call Transcript

2023-05-03 23:45:09 ET Genetic Technologies Limited (GENE) Q3 2023 Earnings Conference Call May 03, 2023 05:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer Tony Di Pietro - Chief Financial Officer Co...
Previous 10 Next 10